$3.21
-0.03-0.93%
At close: Nov 13, 4:00 PM EST
$3.21
N/A
After Hours: Nov 13, 4:00 PM EST
MiMedx Group Inc
MDXGNASDAQ
MiMedx fell 54.8% from $7.10 to $3.21, behind the S&P 500's +13.3%. Its worst day was Nov 2 (−15.5%), and its low came Apr 29 at $3.09.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
MiMedx closed at its highest level of the year, 2.1% above where the year started.
+1.8% · S&P 500 −0.3%
EPS of $0.14 beat the $0.10 estimate on $118.1M revenue (est. $105.2M); FY revenue guidance of $340.0M–$360.0M against the $375.0M consensus.
Story events cover the past 12 months · Times ET
−6.4% · S&P 500 −0.6%
MiMedx shares fell 11.6%, while the S&P 500 rose 0.2%.
−11.6% · S&P 500 +0.2%
EPS of $-0.05 missed the $-0.04 estimate on $59.0M revenue (est. $64.0M); FY revenue guidance of $260.0M–$290.0M against the $312.3M consensus.
+8.9% · S&P 500 +1.0%
EPS of $-0.05 missed the $-0.03 estimate on $64.4M revenue (est. $63.5M); FY revenue guidance of $260.0M–$290.0M against the $269.8M consensus.
+0.9%, on 6M shares, the year's heaviest volume · S&P 500 +1.7%
MiMedx shares fell 11.6%, while the S&P 500 rose 0.5%.
−11.6% · S&P 500 +0.5%
EPS of $-0.01 missed the $0.01 estimate on $62.3M revenue (est. $68.7M); FY revenue guidance of $250.0M–$260.0M against the $268.0M consensus.
+0.5% · S&P 500 −0.4%
Where it ended: a close of $3.21 on Nov 13, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $0.01, revenue est. $66.5M).
Nothing in the past 12 months.
All MDXG dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MDXG and SPY from Benzinga historical bars. Not investment advice.
